Renaissance Technologies’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189K | Sell |
|
|||||
|
2025
Q1 | $176K | Buy |
|
|||||
|
2024
Q4 | $186K | Buy |
|
|||||
|
2024
Q3 | $126K | Buy |
|
|||||
|
2024
Q2 | $102K | Buy |
|
|||||
|
2024
Q1 | $265K | Buy |
|
|||||
|
2023
Q4 | $168K | Buy |
|
|||||
|
2023
Q3 | $93K | Buy |
|
|||||
|
2023
Q2 | $149K | Buy |
|
|||||
|
2023
Q1 | $199K | Buy |
|
|||||
|
2022
Q4 | $213K | Sell |
|
|||||
|
2022
Q3 | $250K | Sell |
|
|||||
|
2022
Q2 | $290K | Buy |
|
|||||
|
2022
Q1 | $356K | Sell |
|
|||||
|
2021
Q4 | $423K | Sell |
|
|||||
|
2021
Q3 | $869K | Sell |
|
|||||
|
2021
Q2 | $1.74M | Sell |
|
|||||
|
2021
Q1 | $3.22M | Buy |
|
|||||
|
2020
Q4 | $2.35M | Sell |
|
|||||
|
2020
Q3 | $1.77M | Buy |
|
|||||
|
2020
Q2 | $1.38M | Buy |
|
|||||
|
2020
Q1 | $445K | Buy |
|
|||||
|
2019
Q4 | $322K | Buy |
|
|||||
|
2019
Q3 | $635K | Buy |
|
|||||
|
2019
Q2 | $428K | Buy |
|
|||||
|
2019
Q1 | $219K | Buy |
|
|||||
|
2018
Q4 | $101K | Buy |
|
|||||
|
2018
Q3 | $157K | Buy |
|
|||||
|
2018
Q2 | $165K | Buy |
|
|||||
|
2018
Q1 | $191K | Buy |
|
|||||
|
2017
Q4 | $178K | Buy |
|
|||||
|
2017
Q3 | $106K | Buy |
|
|||||
|
2017
Q2 | $139K | Buy |
|
|||||
|
2017
Q1 | $121K | Buy |
|
|||||
|
2016
Q4 | $124K | Buy |
|
|||||
|
2016
Q3 | $146K | Buy |
|
|||||
|
2016
Q2 | $39K | Buy |
|